Won T, Arifuzzaman M, Parkhurst C, Miranda I, Zhang B, Hu E
Nature. 2025; 638(8049):216-224.
PMID: 39779854
PMC: 11886927.
DOI: 10.1038/s41586-024-08379-9.
Alonso-Pena M, Espinosa-Escudero R, Hermanns H, Briz O, Herranz J, Garcia-Ruiz C
Cells. 2022; 11(24).
PMID: 36552746
PMC: 9777420.
DOI: 10.3390/cells11243983.
Schlezinger J, Puckett H, Oliver J, Nielsen G, Heiger-Bernays W, Webster T
Toxicol Appl Pharmacol. 2020; 405:115204.
PMID: 32822737
PMC: 7503133.
DOI: 10.1016/j.taap.2020.115204.
Oprea T, Bologa C, Brunak S, Campbell A, Gan G, Gaulton A
Nat Rev Drug Discov. 2018; 17(5):317-332.
PMID: 29472638
PMC: 6339563.
DOI: 10.1038/nrd.2018.14.
Keely S, Walters J
Cell Mol Gastroenterol Hepatol. 2017; 2(6):725-732.
PMID: 28174746
PMC: 5247348.
DOI: 10.1016/j.jcmgh.2016.08.004.
Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets.
Moraes L, Unsworth A, Vaiyapuri S, Ali M, Sasikumar P, Sage T
Arterioscler Thromb Vasc Biol. 2016; 36(12):2324-2333.
PMID: 27758768
PMC: 5144997.
DOI: 10.1161/ATVBAHA.116.308093.
Regulation of the cytosolic sulfotransferases by nuclear receptors.
Runge-Morris M, Kocarek T, Falany C
Drug Metab Rev. 2013; 45(1):15-33.
PMID: 23330539
PMC: 3831883.
DOI: 10.3109/03602532.2012.748794.
Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-)....
Hambruch E, Miyazaki-Anzai S, Hahn U, Matysik S, Boettcher A, Perovic-Ottstadt S
J Pharmacol Exp Ther. 2012; 343(3):556-67.
PMID: 22918042
PMC: 11047796.
DOI: 10.1124/jpet.112.196519.
Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition.
Dufer M, Horth K, Wagner R, Schittenhelm B, Prowald S, Wagner T
Diabetes. 2012; 61(6):1479-89.
PMID: 22492528
PMC: 3357280.
DOI: 10.2337/db11-0815.
Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation.
Schuster D, Markt P, Grienke U, Mihaly-Bison J, Binder M, Noha S
Bioorg Med Chem. 2011; 19(23):7168-80.
PMID: 22018919
PMC: 3254253.
DOI: 10.1016/j.bmc.2011.09.056.
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.
Grienke U, Mihaly-Bison J, Schuster D, Afonyushkin T, Binder M, Guan S
Bioorg Med Chem. 2011; 19(22):6779-91.
PMID: 22014750
PMC: 3254236.
DOI: 10.1016/j.bmc.2011.09.039.
Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2).
Whitby R, Stec J, Blind R, Dixon S, Leesnitzer L, Orband-Miller L
J Med Chem. 2011; 54(7):2266-81.
PMID: 21391689
PMC: 4151520.
DOI: 10.1021/jm1014296.
Regulation of FXR transcriptional activity in health and disease: Emerging roles of FXR cofactors and post-translational modifications.
Kemper J
Biochim Biophys Acta. 2010; 1812(8):842-50.
PMID: 21130162
PMC: 3060272.
DOI: 10.1016/j.bbadis.2010.11.011.
Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand.
Li J, Kuruba R, Wilson A, Gao X, Zhang Y, Li S
PLoS One. 2010; 5(11):e13955.
PMID: 21085652
PMC: 2978707.
DOI: 10.1371/journal.pone.0013955.
FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.
Kemper J, Xiao Z, Ponugoti B, Miao J, Fang S, Kanamaluru D
Cell Metab. 2009; 10(5):392-404.
PMID: 19883617
PMC: 2785075.
DOI: 10.1016/j.cmet.2009.09.009.
Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis.
Miao J, Fang S, Lee J, Comstock C, Knudsen K, Kemper J
Mol Cell Biol. 2009; 29(23):6170-81.
PMID: 19805516
PMC: 2786694.
DOI: 10.1128/MCB.00825-09.
Chemical genomics: massively parallel technologies for rapid lead identification and target validation.
Hacksell U, Nash N, Burstein E, Piu F, Croston G, Brann M
Cytotechnology. 2008; 38(1-3):3-10.
PMID: 19003080
PMC: 3449916.
DOI: 10.1023/A:1021169023731.
The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP.
Fang S, Tsang S, Jones R, Ponugoti B, Yoon H, Wu S
J Biol Chem. 2008; 283(50):35086-95.
PMID: 18842595
PMC: 2596376.
DOI: 10.1074/jbc.M803531200.
Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.
MARTIN P, Riley R, Back D, Owen A
Br J Pharmacol. 2007; 153(4):805-19.
PMID: 18037906
PMC: 2259202.
DOI: 10.1038/sj.bjp.0707601.
The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism.
Deng R, Yang D, Radke A, Yang J, Yan B
J Pharmacol Exp Ther. 2006; 320(3):1153-62.
PMID: 17135343
PMC: 4114705.
DOI: 10.1124/jpet.106.113837.